Paper24251394
Dysregulation of neurotrophic and haematopoietic growth factors in Alzheimer's disease: from pathophysiology to novel treatment strategies.
Sopova K and 3 others. Curr Alzheimer Res, 2014. Cited by 67 papers, by iCite.
Cite this record
ConductScience Library. Dysregulation of neurotrophic and haematopoietic growth factors in Alzheimer's disease: from pathophysiology to novel treatment strategies. Papers, record 24251394. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24251394
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Dysregulation of neurotrophic and haematopoietic growth factors in Alzheimer's disease: from pathophysiology to novel treatment strategies.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alzheimer Disease | Major topic |
| Hematopoietic Cell Growth Factors | Major topic |
| Nerve Growth Factors | Major topic |
| Animals | |
| Blood-Brain Barrier | |
| Brain | |
| Humans | |
| Neurogenesis |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT02271750 | IGF and Other Neurotrophic Factors in Patients With Dementia | Background |
Source ClinicalTrials.gov
Cited by36
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 67 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40014269 | Decoding the Role of Neurotrophins in Glycogen Synthase Kinase 3-Beta Regulation in Alzheimer's Disease. | Mol Neurobiol | 2025 | https://conductscience.org/library/papers/40014269 | PubMed |
| 39679463 | Glial Derived Neurotrophic Factor and Schizophrenia Spectrum Disorders: A Scoping Review. | Curr Neuropharmacol | 2025 | https://conductscience.org/library/papers/39679463 | PubMed |
| 38393906 | Harnessing Passive Pulsatile Shear Stress for Alzheimer's Disease Prevention and Intervention. | J Alzheimers Dis | 2024 | https://conductscience.org/library/papers/38393906 | PubMed |
| 38307947 | The significance of glial cell line-derived neurotrophic factor analysis in Progressive Supranuclear Palsy. | Sci Rep | 2024 | https://conductscience.org/library/papers/38307947 | PubMed |
| 37950725 | 1,5-anhydro-D-fructose induces anti-aging effects on aging-associated brain diseases by increasing 5'-adenosine monophosphate-activated protein kinase activity via the peroxisome proliferator-activated receptor-γ co-activator-1α/brain-derived neurotrophic factor pathway. | Aging (Albany NY) | 2023 | https://conductscience.org/library/papers/37950725 | PubMed |
| 37765114 | Neuroprotective Effect of Nosustrophine in a 3xTg Mouse Model of Alzheimer's Disease. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/37765114 | PubMed |
| 37298603 | Transcranial Electromagnetic Wave Treatment: A Fountain of Healthy Longevity? | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37298603 | PubMed |
| 36979937 | Challenging the Pleiotropic Effects of Repetitive Transcranial Magnetic Stimulation in Geriatric Depression: A Multimodal Case Series Study. | Biomedicines | 2023 | https://conductscience.org/library/papers/36979937 | PubMed |
| 36926705 | Emerging roles of astrocytes in blood-brain barrier disruption upon amyloid-beta insults in Alzheimer's disease. | Neural Regen Res | 2023 | https://conductscience.org/library/papers/36926705 | PubMed |
| 36816421 | Overview on brain function enhancement of Internet addicts through exercise intervention: Based on reward-execution-decision cycle. | Front Psychiatry | 2023 | https://conductscience.org/library/papers/36816421 | PubMed |
| 36714669 | Correlation between Aβ1-42, Dnmt3a2, urinary AD7c-NTP and cognitive dysfunction in first-episode and recurrent MDD: A case-control study. | Indian J Psychiatry | 2022 | https://conductscience.org/library/papers/36714669 | PubMed |
| 36005647 | Transcranial Electromagnetic Treatment Stops Alzheimer's Disease Cognitive Decline over a 2½-Year Period: A Pilot Study. | Medicines (Basel) | 2022 | https://conductscience.org/library/papers/36005647 | PubMed |
| 35585867 | Transcranial Electromagnetic Treatment "Rebalances" Blood and Brain Cytokine Levels in Alzheimer's Patients: A New Mechanism for Reversal of Their Cognitive Impairment. | Front Aging Neurosci | 2022 | https://conductscience.org/library/papers/35585867 | PubMed |
| 35404973 | Aggregation chimeras provide evidence of in vivo intercellular correction in ovine CLN6 neuronal ceroid lipofuscinosis (Batten disease). | PLoS One | 2022 | https://conductscience.org/library/papers/35404973 | PubMed |
| 34863115 | Exercise priming with transcranial direct current stimulation: a study protocol for a randomized, parallel-design, sham-controlled trial in mild cognitive impairment and Alzheimer's disease. | BMC Geriatr | 2021 | https://conductscience.org/library/papers/34863115 | PubMed |
| 34826049 | Therapeutic potential of neurotrophic factors in Alzheimer's Disease. | Mol Biol Rep | 2022 | https://conductscience.org/library/papers/34826049 | PubMed |
| 34685770 | The Potential Role of Cytokines and Growth Factors in the Pathogenesis of Alzheimer's Disease. | Cells | 2021 | https://conductscience.org/library/papers/34685770 | PubMed |
| 33762910 | The Impact of Estrogen and Estrogen-Like Molecules in Neurogenesis and Neurodegeneration: Beneficial or Harmful? | Front Cell Neurosci | 2021 | https://conductscience.org/library/papers/33762910 | PubMed |
| 32670157 | Exercise-Based Interventions for Internet Addiction: Neurobiological and Neuropsychological Evidence. | Front Psychol | 2020 | https://conductscience.org/library/papers/32670157 | PubMed |
| 32206191 | Depressive disorders in the elderly and dementia: An update. | Dement Neuropsychol | 2020 | https://conductscience.org/library/papers/32206191 | PubMed |
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BDNF | 627 | PubTator's text mining | https://conductscience.org/library/genes/627 | NCBI Gene |
| CSF3 | 1440 | PubTator's text mining | https://conductscience.org/library/genes/1440 | NCBI Gene |
| CXCL12 | 6387 | PubTator's text mining | https://conductscience.org/library/genes/6387 | NCBI Gene |
| GDNF | 2668 | PubTator's text mining | https://conductscience.org/library/genes/2668 | NCBI Gene |
| KITLG | 4254 | PubTator's text mining | https://conductscience.org/library/genes/4254 | NCBI Gene |
| NGF | 4803 | PubTator's text mining | https://conductscience.org/library/genes/4803 | NCBI Gene |
| VEGFA | 7422 | PubTator's text mining | https://conductscience.org/library/genes/7422 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24251394
GET https://conductscience.org/api/papers/v1/24251394/cited_by?page=2